Drug intelligence / Profile preview

tetrahydrocannabivarin + tetrahydrocannabinol

Development stage
Preclinical
Lead developer
Jazz Pharmaceuticals
Modality
Small Molecules
Administration
Oral, Inhalation
01

Overview

Tetrahydrocannabivarin + tetrahydrocannabinol is a combination of two naturally occurring cannabinoids found in cannabis plants: tetrahydrocannabivarin (THCV) and tetrahydrocannabinol (THC). THCV is structurally similar to THC but possesses a shorter side chain, which results in distinct pharmacological properties. THCV acts primarily as a cannabinoid-1 (CB1) receptor antagonist and a cannabinoid-2 (CB2) receptor partial agonist, contrasting with THC's partial agonist activity at both receptors. THCV has been associated with appetite suppression, improved glycemic control, and potential neuroprotective benefits. THC, the primary psychoactive component of cannabis, activates CB1 and CB2 receptors and is known for its effects on mood, appetite stimulation, and pain modulation. The combination is under investigation for metabolic disorders, neuropathic pain, and other indications, but is not currently approved as a pharmaceutical product.

02

Targets

TRPV2 (Transient receptor potential cation channel subfamily V member 2)HTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))GPR55 (G protein-coupled receptor 55)CNR1 (Cannabinoid receptor 1)

Beyond the preview

Go deeper on tetrahydrocannabivarin + tetrahydrocannabinol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tetrahydrocannabivarin + tetrahydrocannabinol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call